GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Loans Receivable

MDBIF (TrivarX) Loans Receivable : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Loans Receivable?

TrivarX's Loans Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.


TrivarX Loans Receivable Historical Data

The historical data trend for TrivarX's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Loans Receivable Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TrivarX Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TrivarX Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


TrivarX Loans Receivable Related Terms

Thank you for viewing the detailed overview of TrivarX's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Launches Global Corporate Mental Health Product

By Marketwired Marketwired 05-01-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018

Medibio Provides Updated Company Presentation

By Marketwired Marketwired 10-05-2018

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Medibio Releases Corporate Health Product, ilumen™

By Marketwired Marketwired 10-03-2018